Skip to content

Comparison of peripheral vein catheter implantation under ultrasound guidance in the two regions of the antecubital vein and the saphenous vein

Comparison of the success rate and short-term and long-term consequences of peripheral vein catheter implantation under ultrasound guidance in the two regions of the antecubital vein and the saphenous vein, in patients undergoing surgery at Imam Khomeini Hospital in Tehran in 1402

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
IRCT
Registry ID
IRCT20230130057273N2
Enrollment
98
Registered
2025-10-25
Start date
2024-01-23
Completion date
Unknown
Last updated
2025-12-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Condition 1: patients undergoing surgery, requiring successful placement of peripheral vein catheters under ultrasound guidance by comparing outcomes in the antecubital and saphenous veins. Condition 2: Encounter for adjustment and management of vascular access device. Condition 3: Phlebitis and thrombophlebitis of unspecified site. Encounter for adjustment and management of vascular access device Phlebitis and thrombophlebitis of unspecified site

Interventions

Intervention 1: Intervention group: In the antecubital group, a tourniquet is applied to the non-dominant arm to cause venous blood congestion. The antecubital area is prepped and draped with betadine

Sponsors

Tehran University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 65 Years

Inclusion criteria

Inclusion criteria: Patients who are candidates for elective surgery Referred to the operating room with no peripheral venous access No suitable peripheral vein access point based on initial assessment and clinical judgment of the operating room anesthesiologist The duration of the patient's stay in the hospital is three or less days according to the surgeon in charge of the patient

Exclusion criteria

Exclusion criteria: Patients with ASA class greater than 2 Patients needing emergency surgery Patients with coagulation disorder Patients with heart or vascular diseases Patients with infections Patients with chronic kidney disease Patients with diabetes Patients with immunodeficiency diseases Patients who are candidates for surgery with a high bleeding risk Patients who are candidates for long surgery (more than 3 hours) Patients with psychotic diseases or mood disorders or mental retardation Patients with a history of smoking or substance abuse Patients with systolic pressure less than 90 or greater than 160

Design outcomes

Primary

MeasureTime frame
The success rate of peripheral vein catheterization under ultrasound guidance in the antecubital and saphenous veins. Timepoint: The primary outcome is measured immediately following catheter placement, and subsequent measurements are taken at 24 hours and 3 days after the intervention. Method of measurement: Examination through ultrasound in the short axis and long axis view, for final confirmation , injection of 3 ml of sterile saline inside the catheter and Examination through the color doppler ultrasound in the long axis view, as well as clinical examination of subcutaneous extravasation.

Secondary

MeasureTime frame
Pain intensity during catheter placement. Timepoint: immediately following catheter placement. Method of measurement: VAS(Visual analogue scale) pain criteria.;The duration of the procedure. Timepoint: Immediately following catheter placement. Method of measurement: Timing the procedure.;Incidence of hematoma or ecchymosis post-procedure. Timepoint: Immediately following catheter placement, 24 hours and 3 days after intervention. Method of measurement: Visual examination of injection site.;Thrombophlebitis at the site of needling. Timepoint: Immediately following catheter placement, 24 hours and 3 days after intervention. Method of measurement: Visual examination of injection site and Ultrasound.;Delayed extravasation or accumulation of prescribed venous fluid under the skin. Timepoint: Immediately following catheter placement, 24 hours and 3 days after intervention. Method of measurement: Visual examination of injection site.;The amount of changes in mean arterial pressure. Timepoint: Immediately following catheter placement. Method of measurement: MAP(mean arterial pressure) = DP + 1/3(SP – DP) /measure blood pressure using sphygmomanometer.;Heart rate beats per minute. Timepoint: Before procedure and Immediately following catheter placement. Method of measurement: Heart rate monitor.;Longevity of the catheter with successful function. Timepoint: Immediately following catheter placement, 24 hours and 3 days after intervention. Method of measurement: Ultrasound.;Patient satisfaction from the catheter insertion site. Timepoint: 24 hours after intervention. Method of measurement: questionnaire.;Nursing staff's satisfaction with catheter placement site. Timepoint: 24 hours after intervention. Method of measurement: questionnaire.;The need for the peripheral vein access site. Timepoint: During and immediately following catheter placement. Method of measurement: 1. A vein with a bigger anterior-posterior drop equal to 4 mm cannot be found 2. Creating a subcutaneous hem

Countries

Iran (Islamic Republic of)

Contacts

Public ContactBabak Eslami

Tehran University of Medical Sciences

beslami@sina.tums.ac.ir+98 21 6119 0000

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026